Could a brazilian superfruit ease kidney disease complications?

NCT ID NCT06394531

Not yet recruiting Disease control Sponsor: Universidade Federal Fluminense Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether a supplement made from jaboticaba peel can reduce inflammation, oxidative stress, and gut bacteria imbalances in people with chronic kidney disease. Thirty adults will take either the jaboticaba extract or a placebo for one month. Researchers will measure changes in blood and stool samples to see if the supplement has any beneficial effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Jaboticaba peel extract (a dietary supplement rich in phenolic compounds)
What this could lead to: If it works, this could point toward a simple, natural supplement to help manage inflammation and gut health in people with chronic kidney disease.
What could go wrong: This is a very small, early-stage trial with only 30 participants. The supplement may show no benefit, and results may not apply to all kidney disease patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES

Contacts and locations

Locations

Denise Mafra

Rio de Janeiro, Rio de Janeiro, 22260050, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.